Association of proton pump inhibitor use with survival outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Authors

null

BaoQing Chen

Sun Yat-sen University Cancer Center, Guangzhou, China

BaoQing Chen , Chen Yang , Mihnea-Paul Dragomir , Dongmei Chi , Wenyan Chen , George Calin , Qiaoqiao Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Combinations

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2613)

DOI

10.1200/JCO.2022.40.16_suppl.2613

Abstract #

2613

Poster Bd #

268

Abstract Disclosures